Spots Global Cancer Trial Database for renal cancer
Every month we try and update this database with for renal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent | NCT00836745 | Renal Cell Carc... | Non Interventio... | 18 Years - 75 Years | Pfizer | |
| Renal Cancer Detection Using Convolutional Neural Networks | NCT03857373 | Kidney Cancer | - | Zealand University Hospital | ||
| Impact of Telemonitoring for the Management of Side Effects in Patients With Melanoma, Lung or Renal Cancer, Treated With Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy | NCT04605146 | Melanoma Lung Cancer Renal Cancer | Tele-monitoring | 18 Years - | Hospices Civils de Lyon | |
| A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery | NCT06369597 | Liver Cancer Renal Cancer Rectal Cancer | Robotic telesur... Laparoscopic su... | 18 Years - 75 Years | Sun Yat-sen University | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| A Study of HB0025 Injection in Patients With Advanced Renal Cancer | NCT06222125 | Renal Cancer | HB0025 | 18 Years - | Huabo Biopharm Co., Ltd. | |
| Microwave Coagulation in Partial Nephrectomy Protocol | NCT01931462 | Cancer of Kidne... | Microwave pre-c... | 18 Years - | University of Wisconsin, Madison | |
| A Randomized Controlled Trial of the Safety and Efficacy of Robotic Telesurgery Versus Laparoscopic Surgery | NCT06369597 | Liver Cancer Renal Cancer Rectal Cancer | Robotic telesur... Laparoscopic su... | 18 Years - 75 Years | Sun Yat-sen University | |
| Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor | NCT03239145 | Advanced Solid ... | Pembrolizumab Trebananib | 18 Years - | Dana-Farber Cancer Institute | |
| BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC) | NCT01453595 | Renal Cancer | BEZ235 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells | NCT05108077 | Bladder Cancer Renal Cancer | cytokine-induce... Standard treatm... | 18 Years - 80 Years | Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | |
| Percutaneous Cryoablation Versus Partial Nephrectomy for T1b Renal Tumor | NCT04506671 | Renal Tumor | Renal biopsy Cryoablation Partial nephrec... | 18 Years - | I.M. Sechenov First Moscow State Medical University | |
| Hereditary Leiomyomatosis Renal Cell Cancer - Study of the Genetic Cause and the Predisposition to Renal Cancer | NCT00050752 | Renal Tumor His... Cutaneous Leiom... Kidney Cancer | 2 Years - | National Institutes of Health Clinical Center (CC) | ||
| CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer | NCT01218867 | Metastatic Canc... Metastatic Mela... Renal Cancer | Anti-VEGFR2 CAR... Cyclophosphamid... Aldesleukin Fludarabine | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Study of NS-9 in Patients With Liver Metastases | NCT00094003 | Liver Neoplasms Neoplasm Metast... Local Neoplasm ... | NS-9 [Poly I: P... | 18 Years - | NS Pharma, Inc. | |
| LPN in Patients With High-complex Renal Tumors | NCT04933604 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Oncology Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | laparoscopic pa... Laparoscopic ra... | 18 Years - 80 Years | Samsun Liv Hospital | |
| Vascular Targeted Photodynamic Therapy T1a Renal Tumours | NCT01573156 | Renal Cancer | Light activated... | 60 Years - 90 Years | University of Oxford | |
| Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer | NCT02504892 | Renal Cancer Birt-Hogg-Dube ... | Everolimus | 18 Years - 100 Years | National Institutes of Health Clinical Center (CC) | |
| RNA-Loaded Dendritic Cell Cancer Vaccine | NCT00087984 | Renal Cell Carc... | MB-002 | 18 Years - | Argos Therapeutics | |
| Spectroscopy With Surface Coils and Decoupling | NCT00581815 | Adrenal Cortica... Brain Cancer Breast Cancer CNS Cancer Colon Cancer HEENT Cancer Hodgkin's Disea... Kaposi's Sarcom... Liver Cancer Lung Cancer Non-Hodgkin's L... Ovarian Cancer Pancreatic Canc... Prostate Cancer Rectal Cancer Renal Cancer Sarcoma Squamous Cell C... Thyroid Cancer | Proton-decouple... 1H Spectroscopy... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer - an Observational Trial | NCT06145139 | Renal Cancer | 18 Years - | University of Aarhus | ||
| A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers | NCT05544929 | Carcinoma, Non-... Cutaneous Melan... Carcinoma, Rena... Carcinoma, Ovar... Nasopharyngeal ... Carcinoma, Thym... Anal Cancer Mesothelioma Esophagogastric... High Microsatel... Squamous Cell C... Triple Negative... | KFA115 pembrolizumab | 18 Years - | Novartis | |
| Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies | NCT00496860 | Progressive Met... | ALT-801 | 18 Years - | Altor BioScience | |
| HPI Effect in Robotic Urological Surgery on AKI | NCT06051162 | Prostate Cancer Renal Cancer Urologic Diseas... | BP management w... | 19 Years - | Ewha Womans University Mokdong Hospital | |
| Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2 | NCT00425035 | Advanced Renal ... | Panitumumab (AB... | - | Amgen | |
| Effect of Neuromuscular Block and Arterial PCO2 on Surgical Rating Scale (SRS), Following Reversal With Sugammadex | NCT01968447 | Prostate Cancer Renal Cancer | hypocapnia normocapnia | 18 Years - | Leiden University Medical Center | |
| FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors | NCT03319459 | HER2 Positive G... Colorectal Canc... Head and Neck S... EGFR Positive S... Advanced Solid ... HER2-positive B... Hepatocellular ... Non Small Cell ... Renal Cell Carc... Pancreatic Canc... Melanoma | FATE-NK100 Cetuximab Trastuzumab | 18 Years - | Fate Therapeutics | |
| Complication in Laparoscopic Renal and Adrenal Surgery (CLARAS) | NCT05322265 | Adrenal Disease Renal Cancer Surgery--Compli... | laparoscopic su... | 18 Years - 89 Years | University of Palermo | |
| Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer | NCT05285579 | Renal Cell Carc... Renal Cancer Renal Cancer Me... | Blood collectio... Tumour samples | 18 Years - | Assistance Publique - Hôpitaux de Paris | |
| Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers | NCT01005797 | Renal Cancer Non Small Cell ... Soft Tissue Sar... | Panobinostat (L... | 18 Years - | Medical University of South Carolina | |
| Complications Associated With Partial Nephrectomy for Renal Cancer | NCT05168761 | Renal Cancer Partial Nephrec... | partial nephrec... | - | Central Hospital, Nancy, France | |
| Gag-layer in the Urothelium of the Human Upper Urinary Tract | NCT05400291 | Bladder Cancer Renal Cancer | Chondroitin Sul... | 18 Years - | Aarhus University Hospital | |
| Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma | NCT01108445 | Advanced Non-cl... | Everolimus Sunitinib | 18 Years - | Duke University | |
| Mannitol Use During Partial Nephrectomy Prior to Renal Ischemia and Impact on Renal Function Outcomes | NCT01606787 | Renal Cancer | mannitol placebo | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer | NCT00069160 | Lung Neoplasms Ovarian Neoplas... Cervix Neoplasm... Renal Neoplasms | docetaxel tariquidar 99mTc-sestamibi... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Video Education With Result Dependent dIsclosure | NCT05225428 | Genetic Testing Breast Cancer Ovarian Cancer Pancreatic Canc... Prostate Cancer Colorectal Canc... Renal Cancer Melanoma Sarcoma | Video Education Genetic Counsel... | 18 Years - | Dana-Farber Cancer Institute | |
| CyberKnife for Unresectable Renal Tumors | NCT00807339 | Renal Cancer | Stereotactic ra... CyberKnife Robo... | 18 Years - 95 Years | Beth Israel Deaconess Medical Center | |
| Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies | NCT01109394 | Sarcoma Endocrine Tumor... Neuroblastoma Retinoblastoma Renal Cancer | 4 Weeks - | National Institutes of Health Clinical Center (CC) | ||
| Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF | NCT00458536 | Renal Cancer | Dendritic Cell ... Granulocyte Mac... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Multiparametric MRI for Diagnosing Small Renal Tumors | NCT03470285 | Renal Cancer | Multiparametric... | 18 Years - | University Hospital, Bordeaux | |
| Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer | NCT03390413 | Renal Cancer | Robot Cryoablation | 18 Years - 99 Years | Aarhus University Hospital | |
| Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 | NCT00199875 | Renal Cell Carc... Kidney Neoplasm Renal Cancer Kidney Cancer | Yttrium-90 conj... | 18 Years - | Ludwig Institute for Cancer Research | |
| CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy | NCT05215470 | Renal Cancer Me... | Nivolumab Ipilimumab | 18 Years - | Hospital das Clínicas de Ribeirão Preto | |
| NSAID Use After Robotic Partial Nephrectomy | NCT05842044 | Kidney Cancer Renal Cancer Renal Neoplasm | Ketorolac Acetaminophen Oxycodone Hydromorphone Ibuprofen | 18 Years - 99 Years | University of Miami | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| A Trial of Belzutifan (PT2977, MK-6482) in Combination With Cabozantinib in Patients With Clear Cell Renal Cell Carcinoma (ccRCC) (MK-6482-003) | NCT03634540 | Renal Cell Carc... Clear Cell Rena... Kidney Cancer Renal Cancer Renal Cell Carc... Renal Cell Canc... Renal Cell Carc... Renal Cell Canc... Kidney | Belzutifan Cabozantinib | 18 Years - | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | |
| Study of Continuous OSI-906 Dosing | NCT00514007 | Advanced Solid ... | OSI-906 | 18 Years - | Astellas Pharma Inc | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Perifosine + Sunitinib Malate for Patients With Advanced Cancers | NCT00399152 | Renal Cancer GIST | Perifosine Sunitinib Malat... | 18 Years - | AEterna Zentaris | |
| Renal Cancer Detection With Liquid Biopsy | NCT05060783 | Renal Cancer Oncocytoma | GaGnostic GaGnostic GaGnostic | 18 Years - | Zealand University Hospital | |
| Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast | NCT00671411 | Renal Cancer Kidney Cancer | Ultrasound with... | 21 Years - 99 Years | Memorial Sloan Kettering Cancer Center | |
| Advanced Diffusion Imaging in Renal Cancer Patients | NCT06116253 | Renal Cancer | Magnetic Resona... Tc-99m Pentetat... | 21 Years - 85 Years | NYU Langone Health | |
| Percutaneous Renal Tumor Cryoablation Followed by Biopsy | NCT01012427 | Renal Cancer | percutaneous cr... | 21 Years - | Memorial Sloan Kettering Cancer Center | |
| A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers | NCT02643303 | Head and Neck S... Breast Cancer Sarcoma Merkel Cell Car... Cutaneous T-Cel... Melanoma Renal Cancer Bladder Cancer Prostate Cancer Testicular Canc... Solid Tumor | Durvalumab Tremelimumab Poly-ICLC | 18 Years - | Ludwig Institute for Cancer Research | |
| Pilot Evaluation of 124I-Iodo-Azomycin Galacto-Pyranoside (*IAZGP) Positron Emission Tomography (PET) in the Imaging of Hypoxic Tumors | NCT00588276 | Cervical Cancer HEENT Cancer Renal Cancer Uterine Cancer CERVIX UTERI NO... RECTUM | 124I-Iodo-Azomy... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) | NCT04498767 | Gynecologic Can... Skin Cancer Head and Neck C... Sarcoma Renal Cancer Bladder Cancer Upper Urinary T... Pancreatic Canc... Hepatobiliary C... Gastric Cancer Small Bowel Can... Esophageal Canc... Melanoma Colon Cancer Oligometastasis | Stereotactic bo... Palliative RT | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Phase 1 Study of OSI-930 in Cancer Patients | NCT00513851 | Advanced Solid ... | OSI-930 OSI-930 | 18 Years - | Astellas Pharma Inc | |
| 64Cu-GRIP B in Patients With Advanced Malignancies | NCT05888532 | Prostate Cancer Renal Cancer Urethral Cancer Advanced Solid ... Metastatic Cast... Solid Tumor, Ad... | Copper-64 label... Positron Emissi... | 18 Years - | University of California, San Francisco | |
| Stereotactic Body Radiotherapy (SBRT) for Medically Inoperable Localised Renal Tumors (SABINA Trial) | NCT05817604 | Kidney Neoplasm Renal Cancer Inoperable Dise... SBRT SABR | SBRT | 18 Years - 100 Years | Consorci Sanitari de Terrassa | |
| Laparoscopic Partial Nephrectomy for cT1 Tumors | NCT04213157 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Surgery--Compli... Renal Functiona... Oncology Oncology Proble... Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | 18 Years - 82 Years | Samsun Liv Hospital | ||
| Vaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF | NCT00458536 | Renal Cancer | Dendritic Cell ... Granulocyte Mac... | 18 Years - | Beth Israel Deaconess Medical Center | |
| Study Testing the Biologic Activity and Safety of an Immunotherapeutic in Patients With Newly Diagnosed Stage IV Kidney Cancer | NCT00272649 | Renal Cell Carc... | AGS-003 | 18 Years - | Argos Therapeutics | |
| Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma | NCT01582204 | Renal Cancer | 124IcG250 | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Kidney Cancer Observational Protocol | NCT06147349 | Renal Cancer | Radical or part... | 18 Years - | IRCCS San Raffaele | |
| Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma | NCT00418496 | Renal Cancer Melanoma | Aldesleukin Sorafenib | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| A Rollover Protocol for Subjects Previously Treated With AGS-003 | NCT01482949 | Renal Cell Carc... | AGS-003 | 18 Years - | Argos Therapeutics | |
| LPN in Patients With High-complex Renal Tumors | NCT04933604 | Renal Cancer Renal Neoplasm Renal Cell Carc... Surgery Oncology Kidney Ischemia Kidney Injury Urologic Neopla... Urologic Cancer Kidney Neoplasm... | laparoscopic pa... Laparoscopic ra... | 18 Years - 80 Years | Samsun Liv Hospital | |
| Study of Panobinostat in Combination With Sorafenib in Kidney, Soft Tissue or Lung Cancers | NCT01005797 | Renal Cancer Non Small Cell ... Soft Tissue Sar... | Panobinostat (L... | 18 Years - | Medical University of South Carolina | |
| Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma. | NCT04213664 | Renal Cell Carc... Progression Lymphocyte Diso... Monocytosis Local Disease | prognosis | 18 Years - | Corporacion Parc Tauli | |
| Off Clamp Randomization | NCT01732120 | Renal Cancer Renal Ischemia | Off-clamp parti... | 18 Years - | Washington University School of Medicine | |
| Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment | NCT00678119 | Renal Cell Carc... | AGS-003 Sunitinib | 18 Years - | Argos Therapeutics | |
| A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | NCT00381173 | Breast Cancer Ovarian Cancer Prostate Cancer Colon Cancer Renal Cancer | Cyclophosphamid... | 18 Years - | Eisai Inc. | |
| Contrast Ultrasound Dispersion Imaging (CUDI) as a Diagnostic Modality in the Diagnosis of Renal Cell Carcinoma | NCT04669613 | Kidney Cancer | CUDI | 18 Years - | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | |
| Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250 | NCT00199875 | Renal Cell Carc... Kidney Neoplasm Renal Cancer Kidney Cancer | Yttrium-90 conj... | 18 Years - | Ludwig Institute for Cancer Research | |
| Metronomic Chemotherapy in Wilms Tumor (MetroWilms-1906) | NCT05384821 | Wilms Tumor | Vincristine Irinotecan Temozolomide Etoposide Cis-Retinoic ac... | 18 Months - 17 Years | Centre Oscar Lambret | |
| Renal Cancer Detection Using Convolutional Neural Networks | NCT03857373 | Kidney Cancer | - | Zealand University Hospital | ||
| CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer | NCT01218867 | Metastatic Canc... Metastatic Mela... Renal Cancer | Anti-VEGFR2 CAR... Cyclophosphamid... Aldesleukin Fludarabine | 18 Years - 70 Years | National Institutes of Health Clinical Center (CC) | |
| Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma | NCT00827359 | Renal Cell Carc... Renal Cancer | Everolimus | 18 Years - | Dana-Farber Cancer Institute | |
| Impact of Telemonitoring for the Management of Side Effects in Patients With Melanoma, Lung or Renal Cancer, Treated With Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy | NCT04605146 | Melanoma Lung Cancer Renal Cancer | Tele-monitoring | 18 Years - | Hospices Civils de Lyon |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
